<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03953053</url>
  </required_header>
  <id_info>
    <org_study_id>FL5940-0001-CN</org_study_id>
    <nct_id>NCT03953053</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of FLACS With the FEMTO LDV Z8 Laser Compared to Conventional Cataract Surgery in Chinese Patients</brief_title>
  <acronym>Z8CAT01</acronym>
  <official_title>Safety and Efficacy of FLACS With the FEMTO LDV Z8 Laser Compared to Conventional Cataract Surgery in Chinese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziemer Ophthalmic Systems AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ziemer Ophthalmic Systems AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial will be designed as a multi-center randomized non-inferiority clinical trial to
      demonstrate safety and efficacy of the FEMTO LDV Z8 laser for cataract surgery in a Chinese
      population in China compared to the conventional technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this three center, prospective, interventional, randomized controlled study we aim to
      determine safety and efficacy of the FEMTO LDV Z8 laser as compared to conventional technique
      in Chinese patients diagnosed with cataract of any severity grade that are eligible to
      undergo cataract surgery with age 50 years and a maximum age of 80 years in China.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial cell loss</measure>
    <time_frame>4 month</time_frame>
    <description>To determine whether the FLACS with the FEMTO LDV Z8 laser is non-inferior to measured using the NSP 9900, KONAN MEDICAL, and calculated according to: postoperative endothelial cell loss = preoperative endothelial count - postoperative endothelial cell count</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra- and post- surgical complications</measure>
    <time_frame>4 month</time_frame>
    <description>Diagnosis of Complications in combination with usual follow-up measures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative dissipated energy (CDE)</measure>
    <time_frame>4 month</time_frame>
    <description>Recording of CDE on Phaco device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ultrasound (US) total time</measure>
    <time_frame>4 month</time_frame>
    <description>Record of US Energy applied</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated fluid usage (EFU)</measure>
    <time_frame>4 month</time_frame>
    <description>Record of EFU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal thickness (CCT)</measure>
    <time_frame>4 month</time_frame>
    <description>Mesurement of the Central Corneal Thickness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected distance visual acuity (UDVA)</measure>
    <time_frame>4 month</time_frame>
    <description>Measurement of UDVA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corrected distance visual acuity (CDVA)</measure>
    <time_frame>4 month</time_frame>
    <description>Measurement of CDVA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>FLACS Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Femto Laser treated (anterior Capsulotomy and Fragmentation of lens body before phaco emulification)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gold Standard Method with manual rhexis with pinzette and phaco emulsification</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond Laser Assissted Cataract Surgery</intervention_name>
    <description>During routine Catarct Surgery the Femtolaser cuts a ACCC (Anterior Continous Curvilinear Capsulotomy) into the lensbag and fragmentise the cataract affilited lens body</description>
    <arm_group_label>FLACS Group</arm_group_label>
    <arm_group_label>Manual Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligible to undergo cataract extraction by phacoemulsification with primary
             intraocular lens implantation

          -  Provision of signed and dated informed consent form

          -  Male or female, between 50 and 80 years of age (50 and 80 are included).

          -  IOL chosen for implantation a monofocal aspheric IOL of 6mm optic diameter

          -  Willing to comply with all study procedures and able to return for scheduled follow-up
             examinations

          -  Willing to adhere to the medication (to prevent inflammation and infection) regimen

        Exclusion Criteria:

          -  Corneal disease or pathology, such as corneal scaring or opacity, that precludes
             transmission of laser wavelength or that distorts laser light

          -  Poorly dilating pupil or other defect of the pupil that prevents the iris from
             adequate retraction peripherally (e.g., intraoperative floppy iris syndrome)

          -  Glaucoma or ocular hypertension, pseudoexfoliation

          -  Corneal endothelial pathology where endothelial cell count is compromised (Fuchs
             endothelial dystrophy and others)

          -  Complicated cataract, such as traumatic, white, intumescent or posterior and anterior
             subcapsular cataracts

          -  Nystagmus or hemofacial spasm preventing placement of the patient interface

          -  Previous intraocular or corneal surgery of any kind, including any type of surgery for
             either refractive or therapeutic purposes in either eye

          -  Allergy to medications required in surgery, pre- and post-operative treatment

          -  History of lens or zonular instability

          -  Keratoconus or keratectasia

          -  Immune compromised or diagnosis of ophthalmic disease: ocular herpes zoster or
             simplex, lupus, collagenosis and other acute or chronic illnesses that increases the
             risk to the subject or confounds the outcomes of this study in the opinion of the
             study PI (Principal Investigator)

          -  Anterior chamber depth (ACD) &lt; 1.5 mm or &gt; 4.8 mm as measured from the corneal
             endothelium.

          -  Developmental disability or cognitive impairment that would make informed consent and
             the assessment of visual acuity impossible

          -  Concurrent participation in another ophthalmological clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A-Yong Yu, MD PHD Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Eye Hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olga Grossenbacher, MD</last_name>
    <phone>0041 79 671 6725</phone>
    <email>olga.grossenbacher@ziemergroup.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nikolaus T Kaiser, Dipl.-Ing</last_name>
    <phone>0041799180588</phone>
    <email>nikolaus.kaiser@ziemergroup.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ziemer Ophthalmic Systems AG</name>
      <address>
        <city>Port</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregor Schmid</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 15, 2019</study_first_submitted>
  <study_first_submitted_qc>May 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2019</study_first_posted>
  <last_update_submitted>May 19, 2020</last_update_submitted>
  <last_update_submitted_qc>May 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Femto Cataract Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

